ARTHROPLASTY
The mid-term effects of total hip arthroplasty on health-related quality of life
Osteoarthritis Cartilage. 2014 Mar;22(3):389-406. doi: 10.1016/j.joca.2013.12.006. Epub 2014 Jan 1.20 studies (1 level I; 7 level II; 11 level III; and 1 level IV) comparing health-related quality of life (HRQOL) from baseline to mid-term (between 3.6 to 7 years postoperatively) in patients who underwent total hip arthroplasty (THA) were included in this review. The purpose of this systematic review and meta-analysis was to determine whether THA has an effect on mid-term HRQOL. Results indicated that THA significantly improved both disease-specific and generic HRQOL in the mid-term. The female sex, older age, and pain reported at other sites were found to be predictors of poor mid-term HRQOL.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
